Gevorg Tamamyan: Happy Birthday OncoDaily

FDA Grants Approval for Oral Decitabine/Cedazuridine with Venetoclax in Newly Diagnosed AML

How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Herbert Loong Invites to Attend the Sarcoma Grand Rounds at ASCO 2026

Grand Rounds by OncoDaily: AI in Oncology Edition

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

Khorana Score (Cancer-Associated VTE Risk)

Estimate VTE risk in ambulatory cancer patients using the validated Khorana score.

Khorana Score Points:

  • Very high-risk site (Stomach, Pancreas): +2
  • High-risk site (Lung, Lymphoma, Gynecologic, Bladder, Testicular): +1
  • Platelets ≥350 ×10⁹/L: +1
  • Hemoglobin <10 g/dL or ESA use: +1
  • WBC >11 ×10⁹/L: +1
  • BMI ≥35 kg/m²: +1

Risk Categories:

  • Low risk: 0 points
  • Intermediate risk: 1-2 points
  • High risk: ≥3 points